Search results :

Progressive multifocal leukoencephalopathy

Definition: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Synonyms (terms occurring on more labels are shown first): progressive multifocal leukoencephalopathy, progressive multifocal leucoencephalopathy

More information: PubMed search and possibly Wikipedia

Show drugs for which this side effect directly occurs

Drugs with this side effect as MedDRA Preferred Term

  • FAMP
    • Progressive multifocal leukoencephalopathy
  • bortezomib
    • Progressive multifocal leukoencephalopathy: postmarketing
  • darunavir
    • Progressive multifocal leukoencephalopathy
  • fludarabine
    • Progressive multifocal leukoencephalopathy: postmarketing
  • ifosfamide
    • Progressive multifocal leukoencephalopathy: postmarketing
  • mycophenolate mofetil
    • Progressive multifocal leukoencephalopathy
  • mycophenolic acid
    • Progressive multifocal leukoencephalopathy: postmarketing
  • nelarabine
    • Progressive multifocal leukoencephalopathy
  • ofatumumab
    • Progressive multifocal leukoencephalopathy
  • rapamycin
    • Progressive multifocal leukoencephalopathy: postmarketing
  • saquinavir
    • Progressive multifocal leukoencephalopathy
  • tacrolimus
    • Progressive multifocal leukoencephalopathy: postmarketing
  • tipranavir
    • Progressive multifocal leukoencephalopathy
  • v 1784
    • Progressive multifocal leukoencephalopathy: postmarketing